Literature DB >> 15009102

Analysis of APAF-1 expression in human cutaneous melanoma progression.

Alfonso Baldi1, Daniele Santini, Patrizia Russo, Caterina Catricalà, Ada Amantea, Mauro Picardo, Fabiana Tatangelo, Gerardo Botti, Emanuele Dragonetti, Raffaele Murace, Giuseppe Tonini, Pier Giorgio Natali, Feliciano Baldi, Marco G Paggi.   

Abstract

APAF-1 plays a pivotal role in mitochondria-dependent apoptosis, binding to cytochrome c and favoring activation of caspase-9. It has been shown that epigenetic silencing of the APAF-1 gene is a common event in several metastatic melanoma cells in vitro. We determined, by Western blot, variation in the level of expression of APAF-1 in several human melanoma cell lines and, by immunohistochemistry, in a group of 106 histological samples including benign and malignant melanocytic lesions. We observed APAF-1 down-regulation or loss of expression in two metastatic melanoma cell lines, compared to primary melanoma cell lines. The immunohistochemical analysis revealed a significant difference in APAF-1 staining between nevi and melanomas. In addition, we found a significant negative correlation between APAF-1 expression level and tumor thickness and between primary melanomas and metastases. We conclude that loss of APAF-1 expression can be considered as an indicator of malignant transformation in melanoma.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15009102     DOI: 10.1111/j.0906-6705.2004.00136.x

Source DB:  PubMed          Journal:  Exp Dermatol        ISSN: 0906-6705            Impact factor:   3.960


  11 in total

1.  Loss of APAF-1 expression is associated with early recurrence in stage I, II, and III colorectal cancer.

Authors:  Byung Kyu Ahn; Sung Hoo Kim; Seung Sam Paik; Kang Hong Lee
Journal:  Langenbecks Arch Surg       Date:  2016-08-02       Impact factor: 3.445

2.  Biomarkers: the useful and the not so useful--an assessment of molecular prognostic markers for cutaneous melanoma.

Authors:  Bonnie E Gould Rothberg; David L Rimm
Journal:  J Invest Dermatol       Date:  2010-06-17       Impact factor: 8.551

3.  Rationales for expression and altered expression of apoptotic protease activating factor-1 gene in gastric cancer.

Authors:  He-Ling Wang; Han Bai; Yan Li; Jun Sun; Xue-Qing Wang
Journal:  World J Gastroenterol       Date:  2007-10-14       Impact factor: 5.742

Review 4.  Dysregulation of apoptotic signaling in cancer: molecular mechanisms and therapeutic opportunities.

Authors:  Jessica Plati; Octavian Bucur; Roya Khosravi-Far
Journal:  J Cell Biochem       Date:  2008-07-01       Impact factor: 4.429

5.  Apaf1 apoptotic function critically limits Sonic hedgehog signaling during craniofacial development.

Authors:  A B Long; W J Kaiser; E S Mocarski; T Caspary
Journal:  Cell Death Differ       Date:  2013-07-26       Impact factor: 15.828

6.  Serine protease HtrA1 associates with microtubules and inhibits cell migration.

Authors:  Jeremy Chien; Takayo Ota; Giovanni Aletti; Ravi Shridhar; Mariarosaria Boccellino; Lucio Quagliuolo; Alfonso Baldi; Viji Shridhar
Journal:  Mol Cell Biol       Date:  2009-05-26       Impact factor: 4.272

Review 7.  Apoptosis as anticancer mechanism: function and dysfunction of its modulators and targeted therapeutic strategies.

Authors:  Giuseppa Pistritto; Daniela Trisciuoglio; Claudia Ceci; Alessia Garufi; Gabriella D'Orazi
Journal:  Aging (Albany NY)       Date:  2016-04       Impact factor: 5.682

8.  Tumor necrosis is associated with increased alphavbeta3 integrin expression and poor prognosis in nodular cutaneous melanomas.

Authors:  Ingeborg M Bachmann; Rita G Ladstein; Oddbjørn Straume; George N Naumov; Lars A Akslen
Journal:  BMC Cancer       Date:  2008-12-05       Impact factor: 4.430

9.  Upregulation of apoptotic protease activating factor-1 expression correlates with anti-tumor effect of taxane drug.

Authors:  Meysam Bakhshoudeh; Kayhan Mehdizadeh; Saman Hosseinkhani; Farangis Ataei
Journal:  Med Oncol       Date:  2021-06-28       Impact factor: 3.064

10.  Reduced Apaf-1 expression in human cutaneous melanomas.

Authors:  D L Dai; M Martinka; J A Bush; G Li
Journal:  Br J Cancer       Date:  2004-09-13       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.